University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover meaningful treatments for metabolic diseases.
The Pew Charitable Trusts today announced that Rachel Dutton and Elizabeth Villa, researchers in UC San Diego’s Division of Biological Sciences, have been selected as Pew scholars in biomedical sciences.
Radiation therapy (RT) using high-energy particles is a common and critical component in successfully treating patients with brain tumors but it is also associated with significant adverse effects. In a new study, researchers at the University of California San Diego School of Medicine report that irradiation…
Lesions of the appendix are being over diagnosed as invasive cancer, report University of California San Diego School of Medicine researchers in a paper published June 7 in the journal PLOS ONE.
Researchers at University of California San Diego School of Medicine report that cancer cells appear to communicate to other cancer cells, activating an internal mechanism that boosts resistance to common chemotherapies and promotes tumor survival.
One-third of American children are overweight or obese. Family-based treatment (FBT) has been considered the best model for the treatment of obese children as it provides both parents and children with education and behavior therapy techniques but is provided mainly in a hospital setting. Researchers…
Unusually warm nights can harm human sleep, researchers show, and the poor and the elderly are most affected. Rising temperatures could make sleep loss more severe.
In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently…
UC San Diego and University of Notre Dame scientists report in a May issue of PLOS Computational Biology that a new technique can open up the field of nanopore-based protein identification, even in complex mixtures of different types of molecules.
Researchers have developed a new device to map the brain during surgery and distinguish between healthy and diseased tissues. The device provides higher resolution neural readings than existing tools used in the clinic and could enable doctors to perform safer, more precise brain surgeries.